Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Clinical trial NCT00003593 · COMPLETED

Trial details

NCT number: NCT00003593
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 1999-06-01
Primary completion: 2007-03-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.